Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial
Sign Up to like & getrecommendations! Published in 2023 at "Cephalalgia"
DOI: 10.1177/03331024231161745
Abstract: Background Following the CENTURION phase 3 randomized controlled trial’s four-month double-blind phase, this 12-month open-label extension collected data for up to one year about dose optimization, patterns of use, migraine-related disability, and quality of life… read more here.
Keywords: extension; label extension; trial; lasmiditan patients ... See more keywords